Action Unum Therapeutics - UMRX

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

2,35

Prix Achat

2,35

Prix Vente

2,40

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

202,391M

Clôture Veille

2,35

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

86 124 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,05

Bénéfice par action (BPA)

-2,23

Chiffre d'affairess

Bénéfice net

-192,41M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.unumrx.com

Siège social

Dover, Delaware, USA

Fondé

Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq:...

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress Cogent Biosciences...

SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics

SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, MassachusettsUnum’s former...

Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO

Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO Transaction focused on the BOXR technology including lead program...

Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates Completed...

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC Acquisition includes lead clinical-stage compound...

Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates

CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical...

Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates

CAMBRIDGE, Mass., March 26, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a...

Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital

CAMBRIDGE, Mass., March 20, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a...

Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cance...

BOXR1030 is a GPC3-targeted CAR T cell incorporating the novel GOT2 transgene designed to improve T cell...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

UMRX - Frequently Asked Questions (FAQ)

What is the current Unum Therapeutics share price?

The current share price of Unum Therapeutics is US$ 2,35

How many Unum Therapeutics shares are in issue?

Unum Therapeutics has 86 124 000 shares in issue

What is the market cap of Unum Therapeutics?

The market capitalisation of Unum Therapeutics is USD 202,39M

What is the 1 year trading range for Unum Therapeutics share price?

Unum Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Unum Therapeutics?

The price to earnings ratio of Unum Therapeutics is -1,05

What is the reporting currency for Unum Therapeutics?

Unum Therapeutics reports financial results in USD

What is the latest annual profit for Unum Therapeutics?

The latest annual profit of Unum Therapeutics is USD -192,41M

What is the registered address of Unum Therapeutics?

The registered address for Unum Therapeutics is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904

What is the Unum Therapeutics website address?

The website address for Unum Therapeutics is www.unumrx.com

Which industry sector does Unum Therapeutics operate in?

Unum Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
JTAIJet AI Inc	US$ 6,02 (133,33%)	101,64M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	248,48M
WRDWeRide Inc	US$ 31,4877 (83,39%)	20,57M
INLFINLIF Limited	US$ 16,27 (80,58%)	7,67M
MBRXMoleculin Biotech Inc	US$ 2,1201 (66,94%)	134,88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3,08 (-56,31%)	425,19k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3,36 (-52,68%)	5,21k
CSAICloudastructure Inc	US$ 19,0001 (-49,58%)	1,01M
NEXNNexxen International Ltd	US$ 10,30 (-49,16%)	160,99k
BSLKBolt Projects Holdings Inc	US$ 0,6626 (-46,13%)	13,07M
CNSPCNS Pharmaceuticals Inc	US$ 0,1415 (31,26%)	489,28M
MGOLMGO Global Inc	US$ 0,7176 (-15,08%)	417,31M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	254,39M
INTCIntel Corporation	US$ 23,60 (-2,20%)	230,26M
NVDANVIDIA Corporation	US$ 138,85 (2,63%)	194,99M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Unum Therapeutics Inc (UMRX)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Unum Therapeutics Inc

UMRX Dernières nouvelles

Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress

SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics

Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO

Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates

Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates

Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital

Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cance...

UMRX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Unum Therapeutics Inc (UMRX) Cours

Unum Therapeutics Inc (UMRX)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Unum Therapeutics Inc

UMRX Dernières nouvelles

Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress

SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics

Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO

Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates

Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates

Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital

Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cance...

UMRX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS